-
Polish Journal of Microbiology Jun 2018Brucellae are Gram-negative, small rods infecting mammals and capable of causing disease called brucellosis. The infection results in abortion and sterility in domestic... (Review)
Review
Brucellae are Gram-negative, small rods infecting mammals and capable of causing disease called brucellosis. The infection results in abortion and sterility in domestic animals (sheeps, pigs, rams etc). Especially dangerous for humans are: Brucella melitensis, Brucella suis, Brucella abortus, and Brucella canis that trigger unspecific symptoms (flu-like manifestation). Brucella rods are introduced via host cells, by inhalation, skin abrasions, ingestion or mucosal membranes. The most important feature of Brucella is the ability to survive and multiply within both phagocytic and non-phagocytic cells. Brucella does not produce classical virulence factors: exotoxin, cytolisins, exoenzymes, plasmids, fimbria, and drug resistant forms. Major virulence factors are: lipopolysaccharide (LPS), T4SS secretion system and BvrR/BvrS system, which allow interaction with host cell surface, formation of an early, late BCV (Brucella Containing Vacuole) and interaction with endoplasmic reticulum (ER) when the bacteria multiply. The treatment of brucellosis is based on two-drug therapy, the most common combinations of antibiotics are: doxycycline with rifampicin or fluoroquinolones with rifampicin. Currently, also other methods are used to disrupt Brucella intracellular replication (tauroursodeoxycholic acid or ginseng saponin fraction A).
Topics: Animals; Anti-Bacterial Agents; Brucella; Brucellosis; Endoplasmic Reticulum; Host-Pathogen Interactions; Humans; Lipopolysaccharides; Macrophages; Sheep; Swine; Type IV Secretion Systems; Virulence Factors
PubMed: 30015453
DOI: 10.21307/pjm-2018-029 -
Emerging Microbes & Infections Dec 2023The zoonotic bacteria, , is becoming the leading cause of canine brucellosis in Europe. In dogs, it causes reproductive problems as well as non-specific lameness or... (Review)
Review
The zoonotic bacteria, , is becoming the leading cause of canine brucellosis in Europe. In dogs, it causes reproductive problems as well as non-specific lameness or discospondilitis. In humans, can be origin of chronic debilitating conditions characteristic to its genus such as undulant fever, splenomegaly, and lymphadenopathy. Although shows some pathogenic characteristics similar to and , it lacks surface O-polysaccharide, like nonzoonotic . This review shows that host- interactions are still poorly understood, with many knowledge and capability gaps, causing relatively poor sensitivity and specificity of existing diagnostic tools. Currently, there is no vaccine for this rough species. Besides, antimicrobial therapy does not guarantee bacterial elimination, and infection relapses are frequently reported, increasing the risks of antibiotic resistance development. has been detected in dogs in almost all European countries which increased human exposure, but currently there is no systematic surveillance. Moreover, caused brucellosis is not included in Animal Health Law, and therefore there is no legal framework to tackle this emerging infectious disease. To map out the diagnostic strategies, identify risks for human infections and propose management scheme for infected pet and kennel dogs, we present current understanding of canine caused brucellosis, outline major knowledge gaps and propose future steps. To address and highlight challenges veterinary and public health services encounter in Europe, we developed two infection scenarios: of a single household pet and of a kennel dog in larger group.
Topics: Animals; Dogs; Humans; Sheep; Brucella canis; Public Health; Dog Diseases; Brucellosis; Europe
PubMed: 37649455
DOI: 10.1080/22221751.2023.2249126 -
The Veterinary Clinics of North... Sep 2023The genus Brucella is known by veterinarians as a primary cause of reproductive diseases. It is widely known to cause financial devastation in livestock species, and is... (Review)
Review
The genus Brucella is known by veterinarians as a primary cause of reproductive diseases. It is widely known to cause financial devastation in livestock species, and is lesser known as a problem for dog breeders and fanciers with similar reproductive diseases seen in dogs. Now there are concerns about the dispersal of Brucella canis into countries that have enjoyed a fairly low incidence, through the importation of dogs from endemic countries. B canis, much like Brucella abortus, suis or mellitensis, is zoonotic and handling or working with infected dogs can lead to human disease. Only within the last few decades has the risk of brucellosis in dogs, and the people who own and work with them, been more fully acknowledged. This review will focus on new information that has been obtained since our last B canis article in 2018. Readers are encouraged to look to that article for information not presented within this update. Current B canis epidemiology along with a complete review of diagnostic testing options will be covered. Regulations for the international movement of dogs will be discussed in addition to concerns for increased zoonosis potential. Future goals would include better management of this disease including proposed screening of all imported dogs. Canine brucellosis prevention, owner and shelter/rescue education along with proposed therapies for the future will also be explored.
Topics: Humans; Animals; Dogs; Brucella canis; Dog Diseases; Brucellosis; Zoonoses
PubMed: 37385876
DOI: 10.1016/j.cvsm.2023.05.002 -
The Canadian Veterinary Journal = La... Jan 2018In Canada, remains a potentially devastating infectious agent that is still considered uncommon, despite the increasing international movement of dogs. There may be a... (Review)
Review
In Canada, remains a potentially devastating infectious agent that is still considered uncommon, despite the increasing international movement of dogs. There may be a growing risk to the Canadian canine population due to a reliance on outdated seroprevalence studies and the lack of federal regulation. With the complex diagnostic and management challenges associated with a One Health approach is necessary to address the need for ongoing research, including updating canine and human seroprevalence rates in Canada, elucidating the pathogenesis, and determining the most appropriate treatment and prevention strategies. Clinical management decisions are often complicated by currently available treatment protocols, and health risks to both canine and human populations. This article integrates recent research focusing on the pathogenesis, diagnosis, and treatment of and outlines current clinical management approaches.
Topics: Animals; Brucella canis; Brucellosis; Canada; Dog Diseases; Dogs
PubMed: 29302106
DOI: No ID Found -
Revista Argentina de Microbiologia 2021The aim of this study was to estimate the diversity and prevalence of both groups of Brucella canis 1 and 2 with and without deletion respectively in different areas of...
The aim of this study was to estimate the diversity and prevalence of both groups of Brucella canis 1 and 2 with and without deletion respectively in different areas of Argentina. A total of 104 bacterial cultures were typed as B. canis strains using the classical biotyping method. Two PCR assays were performed to confirm that all isolates were B. canis and not Brucella suis. The differentiation between groups 1 and 2 was achieved using another PCR assay and the diversity of B. canis isolates was assessed with four MLVA_16 markers. All strains belonged to Group 2. Bruce 09 marker (MLVA_16 assay) showed the greatest diversity. Only Group 2 of B. canis was identified among the strains evaluated. The markers chosen from the MLVA_16 allowed us to detect genetic diversity among the strains of B. canis studied.
Topics: Argentina; Brucella canis; Brucella suis; Brucellosis; Humans; Polymerase Chain Reaction
PubMed: 33176954
DOI: 10.1016/j.ram.2020.06.012 -
Frontiers in Veterinary Science 2022To describe the clinical and imaging findings of 33 dogs with discospondylitis (BDS).
OBJECTIVE
To describe the clinical and imaging findings of 33 dogs with discospondylitis (BDS).
ANIMALS
33 client owned dogs from four veterinary specialty hospitals within Colorado and Arizona with at least one positive test and spinal diagnostic imaging.
PROCEDURES
Retrospective review of signalment, physical and neurological examination findings, laboratory results, serology, and diagnostic imaging of 33 dogs with BDS. All imaging was reviewed by a board-certified veterinary neurologist. Radiographs were reviewed by a board-certified veterinary radiologist blinded to MRI and CT findings.
RESULTS
31/33 (94%) dogs were <5 years old (median = 2.5 years, mean = 2.9 years, range 0.5-10 years). 21/29 (72%) dogs had signs of nonspecific pain, spinal pain, or lameness for >3 months (median = 6 months, mean = 8.2 months, range 5 days-4 years). Fever was seen in only 4/28 (14%) dogs. Multifocal lesions were evident on radiographs in 21/29 (72%) dogs and MRI in 12/18 (67%) dogs. Smooth, round, central end-plate lysis, defined as "hole punch" lesions, were identified radiographically in 25/29 (86%) dogs. Vertebral physitis or spondylitis without discitis was evident on MRI in 7/18 (39%) dogs.
CLINICAL RELEVANCE
Dogs with BDS typically present at a young age with a long duration of clinical signs. Identification of radiographic "hole punch" lesions and MRI evidence of vertebral physitis, spondylitis, and paravertebral inflammation without discitis should increase suspicion for BDS. BDS may be increasing in frequency in the southwestern United States, and dogs with signs of chronic spinal pain and/or lameness should be screened for .
PubMed: 36406064
DOI: 10.3389/fvets.2022.1043610 -
The Veterinary Record Dec 2022
Topics: Animals; Dogs; Brucella canis; Brucellosis; Species Specificity; Dog Diseases
PubMed: 36524629
DOI: 10.1002/vetr.2561 -
The Veterinary Record
Topics: Animals; Dogs; Brucella canis; Brucellosis; Brucella; Dog Diseases
PubMed: 37326176
DOI: 10.1002/vetr.3180 -
The Veterinary Record Feb 2021
Topics: Animals; Brucella; Brucella canis; Brucellosis; Dog Diseases; Dogs; United Kingdom
PubMed: 34651711
DOI: 10.1002/vetr.227 -
Emerging Infectious Diseases Jul 2021Brucella canis had not been isolated in the Netherlands until November 2016, when it was isolated from a dog imported from Romania. Including this case, 16 suspected... (Review)
Review
Brucella canis had not been isolated in the Netherlands until November 2016, when it was isolated from a dog imported from Romania. Including this case, 16 suspected cases were notified to the authorities during the following 25 months. Of these 16 dogs, 10 were seropositive; tracking investigations found another 8 seropositive littermates. All seropositive animals were rescue dogs imported from Eastern Europe. B. canis was cultured from urine, blood, and other specimens collected from the dogs. Genotyping of isolates revealed clustering by litter and country. Isolating B. canis in urine indicates that shedding should be considered when assessing the risk for zoonotic transmission. This case series proves introduction of B. canis into a country to which it is not endemic through import of infected dogs from B. canis-endemic areas, posing a threat to the naive autochthonous dog population and humans.
Topics: Animals; Brucella canis; Brucellosis; Dog Diseases; Dogs; Europe, Eastern; Netherlands; Romania
PubMed: 34152959
DOI: 10.3201/eid2707.201238